Advisory Services Network’s Amplify Treatments, Testing and Advancements ETF GERM Stock Holding History

Advisory Services Network’s Portfolio GERM Stock Details GERM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-1,000	Closed	-$20.4K	–	3880
2023 Q1	$20.4K	Hold	1,000	–	–	﹤0.01%	2525
2022 Q4	$22.4K	Buy	+1,000	New	+$22.5K	﹤0.01%	2410
2021 Q3	–	Sell	-1,000	Closed	-$40K	–	3419
2021 Q2	$40K	Buy	+1,000	New	+$37.3K	﹤0.01%	2123
2021 Q1	–	Sell	-1,000	Closed	-$31K	–	3106
2020 Q4	$31K	Hold	1,000	–	–	﹤0.01%	1925
2020 Q3	$28K	Buy	+1,000	New	+$29.4K	﹤0.01%	1913

Other funds holding GERM

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Harbour Investments Madison, Wisconsin $6.48B AUM 18.23% 1-Year Est. Return

FDCDDQ

Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

Advisory Services Network's GERM Position: Q2 2023 in Review

Advisory Services Network sold out of Amplify Treatments, Testing and Advancements ETF (GERM) in Q2 2023, closing a stake of 1,000 shares — an estimated $20.4K sold.

Advisory Services Network first reported a position in GERM in Q3 2020 and held it in 5 quarters. The position peaked at $40K in Q2 2021. 17 funds tracked by Wall St. Rank hold GERM as of Q2 2023.

Advisory Services Network reported no remaining Amplify Treatments, Testing and Advancements ETF position as of Q2 2023 after selling out during the quarter.
Advisory Services Network sold 1,000 Amplify Treatments, Testing and Advancements ETF shares in Q2 2023, an estimated $20.4K.
Advisory Services Network first reported a position in Amplify Treatments, Testing and Advancements ETF in Q3 2020 and held it in 5 quarters.
Advisory Services Network's Amplify Treatments, Testing and Advancements ETF position peaked at $40K in Q2 2021.
17 funds tracked by Wall St. Rank held Amplify Treatments, Testing and Advancements ETF as of Q2 2023.

Based on Advisory Services Network's 13F filing for Q2 2023, filed 9 Aug 2023.